clature.nbn.science - references

1

Frazer, A., & Blier, P. (2016). A neuroscience-based nomenclature (NbN) for psychotropic agents. International Journal of Neuropsychopharmacology, 19(8).

2

Krystal, J. H., Abi-Dargham, A., Barch, D. M., Bullmore, E. T., Carter, C. S., Geschwind, D. H., Harrison, P.J., Nestler, E.J. & Stein, M. B. (2016). Biological psychiatry and biological psychiatry: cognitive neuroscience and neuroimaging adopt neuroscience-based nomenclature. Biological psychiatry, 80(1), 2-3.

3

Möller, H. J. (2016). The new neuroscience based nomenclature of neuropsychotropic drugs: A chance for a better understanding and teaching of clinical psychopharmacology. European Psychiatry, 33(S1), S62-S63.

4

Möller, H. J., Schmitt, A., & Falkai, P. (2016). Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications. European archives of psychiatry and clinical neuroscience, 266(5), 385-386.

5

Nutt, D. J., & Blier, P. (2016). Neuroscience-based nomenclature (NbN) for the journal of psychopharmacology. Journal of Psychopharmacology, 30(5), 413-415.

6

Ramadas, S. (2016). Neuroscience-based nomenclature and medicolegal significance. Indian Journal of Psychiatry, 58(3).

7

Uchida, H., Yamawaki, S., Bahk, W. M., & Jon, D. I. (2016). Neuroscience-based Nomenclature (NbN) for clinical psychopharmacology and neuroscience. Clinical Psychopharmacology and Neuroscience, 14(2), 115.

8

Blier, P., Oquendo, M. A., & Kupfer, D. J. (2017). Progress on the Neuroscience-based Nomenclature (NbN) for psychotropic medications. Neuropsychopharmacology, 42(10), 1927-1928.

9

Brühl, A. B., & Sahakian, B. J. (2017). Neuroscience-based Nomenclature: improving clinical and scientific terminology in research and clinical psychopharmacology. Psychological Medicine, 47(8), 1339-1341.

10

Caraci, F., Enna, S. J., Zohar, J., Racagni, G., Zalsman, G., van den Brink, W., Kasper, S., Koob, G.F., Pariante, C.M., Piazza, P.V. and Yamada, K., & Drago, F. (2017). A new nomenclature for classifying psychotropic drugs. British journal of clinical pharmacology, 83(8), 1614-1616.

11

Gorwood, P., Frangou, S., & Heun, R. (2017). Neuroscience-based Nomenclature (NbN) replaces the current label of psychotropic medications in European Psychiatry. European Psychiatry, 40, 123-123.

12

Stahl, S. M. (2017). Neuroscience-based nomenclature: classifying psychotropics by mechanism of action rather than indication. Current Psychiatry, 16(5), 15-16.

13

Kikuchi, Y., Zohar, J., Suzuki, T., Mimura, M., Yagi, G., & Uchida, H. (2018). Mood stabilizers as an Achilles’ heel for indication‐based nomenclature and roles of Neuroscience‐based Nomenclature. Psychiatry and Clinical Neurosciences, 72(12), 854-855.

14

Wilson, S. (2018). Naming the drugs we use: neuroscience-based nomenclature, a helpful innovation. Therapeutic Advances in Psychopharmacology, 8(6), 171-172.

15

Uchida, H. (2018). Neuroscience‐based Nomenclature: What is it, why is it needed, and what comes next?. Psychiatry and Clinical Neurosciences, 72(2), 50-51.

1

Zohar, J., Nutt, D. J., Kupfer, D. J., Moller, H. J., Yamawaki, S., Spedding, M., & Stahl, S. M. (2014). A proposal for an updated neuropsychopharmacological nomenclature. European Neuropsychopharmacology, 24(7), 1005-1014.

2

Zohar, J., Stahl, S., Moller, H. J., Blier, P., Kupfer, D., Yamawaki, S., Uchida, H., Speddingh M., Goodwin G & Nutt, D. (2015). A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature. European Neuropsychopharmacology, 25(12), 2318-2325.

3

Zohar, J., & Kasper, S. (2016). Neuroscience-based Nomenclature (NbN): A call for action. The World Journal of Biological Psychiatry, 17(5), 318-320.

4

Sultan, R. S., Correll, C. U., Zohar, J., Zalsman, G., & Veenstra-VanderWeele, J. (2018). What’s in a name? Moving to neuroscience-based nomenclature in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 57(10), 719.

5

Carton, L., Nourredine, M., & Rolland, B. (2021). Pharmacotherapy of substance use disorders in the Neuroscience-based Nomenclature (NbN). Therapies, 76(2), 127-136.

6

Siafis, S., Davis, J. M., & Leucht, S. (2021). Antipsychotic drugs: From ‘major tranquilizers’ to Neuroscience-based-Nomenclature. Psychological Medicine, 51(3), 522-524.

7

Strawn, J. R., Lu, L., Peris, T. S., Levine, A., & Walkup, J. T. (2021). Research Review: Pediatric anxiety disorders–what have we learnt in the last 10 years?. Journal of Child Psychology and Psychiatry, 62(2), 114-139.

8

Zohar J., & Levy D. M. (2022). Neuroscience-based nomenclature of psychotropics: Progress report. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology, 57, 36-38.

9

Zemach, S., Levy, D. M., & Zohar, J. (2022). Neuroscience-Based Nomenclature as a Teaching Tool, Introduction and pilot study. BMC Medical Education. Submitted.

1

Zohar J., Stahl, S., Moller HJ., Blier P., Kupfer D., Yamawaki S., Uchida H., Spedding M., Goodwin G., Nutt D., 2014. NbNomenclature – Neuroscience based Nomenclature (NbN). Cambridge University Press, University Printing House, Cambridge CB2 8BS, United Kingdom, ISBN 978-1-107-48254-8.

2

Zohar J., Stahl, S., Moller HJ., Blier P., Kupfer D., Yamawaki S., Uchida H., Drago F., Goodwin G., Nutt D., 2017. NbN-2 – Neuroscience-based Nomenclature Second Edition. European College of Neuropsychopharmacology (ECNP).

3

Zohar J., Arango C., Veenstra-VanderWeele J., Stahl, S., Blier P., Nutt D., Kupfer D., Correll C., Uchida H., Drago F., Zuddas A., Zalsman G. 2018. NbN-ca – Neuroscience based Nomenclature Second Edition. European College of Neuropsychopharmacology (ECNP).

4

Zohar J., Stahl, S., Moller HJ., Blier P., Kupfer D., Correll C., Yamawaki S., Uchida H., Drago F., Goodwin G., Nutt D., 2019. NbN-2R – Neuroscience-based Nomenclature Second Edition - Revised. European College of Neuropsychopharmacology (ECNP).

1

Goodwin G., Zohar J., & Kupfer D. (2020). A Neuroscience-based Nomenclature for Psychotropics Drugs. New Oxford textbook of psychiatry: Oxford University Press. Geddes JR, Andreasen NC.

2

Haddad P & Nutt D (2020) Neuroscience-Based Nomenclature Glossary. Seminars in Clinical Psychopharmacology, 3rd edition. Cambridge University Press.

3

Minkin L.D, Zemach S, & Zohar J. (2021). Neuroscience-based Nomenclature (NbN): New pharmacological driven classification of psychotropics. In: Clinica Psiquiatrica: A Terapeutica Psiquiatrica. Manole; p. 6-11.

4

Levy D. M., Zemach S., Goodwin G., Pato M.T & Zohar J. Neuroscience-based Nomenclature (NbN): New Pharmacological Driven Classification of Psychotropics. Tasman’s Psychiatry 5th ed. Springer. In press.

5

Zohar J., Zemach S., & Levy, D. M. The Classification of Psychotropics: Neuroscience-based Nomenclature (NbN). Kaplan & Sadock's Comprehensive Textbook of Psychiatry 11th ed. Wolter Kluwer. In press.

1

Stahl, S. M. (2020). Prescriber's Guide: Stahl's Essential Psychopharmacology. Cambridge University Press.

2

Stahl, S. M. (2020). Stahl's Essential Psychopharmacology. Cambridge University Press.

3

Levy D. M., Zemach S., Goodwin G., Pato M.T & Zohar J. Neuroscience-based Nomenclature (NbN): New Pharmacological Driven Classification of Psychotropics. Tasman’s Psychiatry 5th ed. Springer. In press.

4

Zohar J., Zemach S., & Levy, D. M. The Classification of Psychotropics: Neuroscience-based Nomenclature (NbN). Kaplan & Sadock's Comprehensive Textbook of Psychiatry 11th ed. Wolter Kluwer. In press.

NbN References